Drug Search Results
More Filters [+]

Flibanserin

Alternative Names: flibanserin, addyi
Latest Update: 2024-10-24
Latest Update Note: News Article

Product Description

Flibanserin is a serotonergic antidepressant used to treat hypoactive sexual desire disorder. Flibanserin has been associated with a low rate of minor serum aminotransferase elevations during treatment, but has not been linked to instances of clinically apparent acute liver injury. (Sourced from: https://pubmed.ncbi.nlm.nih.gov/31643404/)

Mechanisms of Action: 5-HT1A Agonist,5-HT2A Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Approved

Approved Countries: Bangladesh | Canada | Egypt | United States

Approved Indications: Generalized anxiety disorder

Known Adverse Events: Dizziness | Insomnia

Company: Sprout
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Flibanserin

Countries in Clinic: United States

Active Clinical Trial Count: 1

Highest Development Phases

Phase 2: Erectile Dysfunction

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

HSDD

P2

Recruiting

Erectile Dysfunction

2024-10-31

Recent News Events